These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9252387)

  • 1. Activated protein C cleavage of factor Va leads to dissociation of the A2 domain.
    Mann KG; Hockin MF; Begin KJ; Kalafatis M
    J Biol Chem; 1997 Aug; 272(33):20678-83. PubMed ID: 9252387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model describing the inactivation of factor Va by APC: bond cleavage, fragment dissociation, and product inhibition.
    Hockin MF; Cawthern KM; Kalafatis M; Mann KG
    Biochemistry; 1999 May; 38(21):6918-34. PubMed ID: 10346914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of inactivation of human factor V and human factor Va by activated protein C.
    Kalafatis M; Rand MD; Mann KG
    J Biol Chem; 1994 Dec; 269(50):31869-80. PubMed ID: 7989361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the membrane in the inactivation of factor Va by activated protein C.
    Kalafatis M; Mann KG
    J Biol Chem; 1993 Dec; 268(36):27246-57. PubMed ID: 8262965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.
    Egan JO; Kalafatis M; Mann KG
    Protein Sci; 1997 Sep; 6(9):2016-27. PubMed ID: 9300501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated protein C-catalyzed inactivation of human factor VIII and factor VIIIa. Identification of cleavage sites and correlation of proteolysis with cofactor activity.
    Fay PJ; Smudzin TM; Walker FJ
    J Biol Chem; 1991 Oct; 266(30):20139-45. PubMed ID: 1939075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C.
    Gale AJ; Xu X; Pellequer JL; Getzoff ED; Griffin JH
    Protein Sci; 2002 Sep; 11(9):2091-101. PubMed ID: 12192065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of factor Va and factor VIIIa by activated platelets.
    Kalafatis M; Rand MD; Jenny RJ; Ehrlich YH; Mann KG
    Blood; 1993 Feb; 81(3):704-19. PubMed ID: 8427963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells.
    Hockin MF; Kalafatis M; Shatos M; Mann KG
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2765-75. PubMed ID: 9409254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals.
    Camire RM; Kalafatis M; Cushman M; Tracy RP; Mann KG; Tracy PB
    J Biol Chem; 1995 Sep; 270(35):20794-800. PubMed ID: 7657663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C.
    Nicolaes GA; Tans G; Thomassen MC; Hemker HC; Pabinger I; Varadi K; Schwarz HP; Rosing J
    J Biol Chem; 1995 Sep; 270(36):21158-66. PubMed ID: 7673148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of membrane-dependent factor Va cleavage: a mechanistic interpretation of the pathology of protein CVermont.
    Lu D; Kalafatis M; Mann KG; Long GL
    Blood; 1994 Aug; 84(3):687-90. PubMed ID: 8043858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: an insight into the APC-resistance assay.
    Kalafatis M; Haley PE; Lu D; Bertina RM; Long GL; Mann KG
    Blood; 1996 Jun; 87(11):4695-707. PubMed ID: 8639839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.
    Rosing J; Hoekema L; Nicolaes GA; Thomassen MC; Hemker HC; Varadi K; Schwarz HP; Tans G
    J Biol Chem; 1995 Nov; 270(46):27852-8. PubMed ID: 7499257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel APC-cleavage sites in FVa provide insights into mechanisms of action of APC and its cofactor protein S.
    Tran S; Dahlbäck B
    J Thromb Haemost; 2010 Jan; 8(1):129-36. PubMed ID: 19874463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va.
    Norstrøm EA; Steen M; Tran S; Dahlbäck B
    J Biol Chem; 2003 Jul; 278(27):24904-11. PubMed ID: 12707283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin.
    Segers K; Dahlbäck B; Rosing J; Nicolaes GA
    J Biol Chem; 2008 Aug; 283(33):22573-81. PubMed ID: 18519572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the membrane in the inactivation of factor va by plasmin. Amino acid region 307-348 of factor V plays a critical role in factor Va cofactor function.
    Kalafatis M; Mann KG
    J Biol Chem; 2001 May; 276(21):18614-23. PubMed ID: 11278331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered inactivation pathway of factor Va by activated protein C in the presence of heparin.
    Nicolaes GA; Sørensen KW; Friedrich U; Tans G; Rosing J; Autin L; Dahlbäck B; Villoutreix BO
    Eur J Biochem; 2004 Jul; 271(13):2724-36. PubMed ID: 15206937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679.
    van der Neut Kolfschoten M; Dirven RJ; Vos HL; Tans G; Rosing J; Bertina RM
    J Biol Chem; 2004 Feb; 279(8):6567-75. PubMed ID: 14660667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.